Top Markets
Coin of the day
Proteome Sciences plc Proteome Sciences plc

Proteome Sciences plc

PRM
주식 순위 #40896
Proteome Sciences plc provides contract research services for the... Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant that provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator which analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids. It also offers top 14 and top 65 super depletion of proteins from serum and plasma; selective reaction monitoring (SRM) and parallel reaction monitoring (PRM) based biomarker assay development; SRM assay, a targeted mass spectrometry assay format for the routine measurement of biomarkers; and TMT SRM, a targeted assay format that enables the rapid validation of biomarker candidates. The company serves its products to pharmaceutical and biotechnology companies, as well as to academic research institutes. The company was incorporated in 1993 and is based in Cobham, the United Kingdom.
주가
$0.02449263
시가총액
$70.76K
변동 (1일)
0.00%
변동 (1년)
-39.87%
국가
GB
거래 Proteome Sciences plc (PRM)

카테고리

Proteome Sciences plc (PRM)의 주식 분할 이력
Proteome Sciences plc 주식 (심볼: PRM)은 총 0회의 주식 분할을 거쳤습니다.
가장 최근의 분할은 Aug 13, 2026에 발생했습니다.
Aug 13, 2026 이전에 매수한 PRM 주식 1주는 현재 0주의 PRM 주식에 해당합니다.
주식 분할 목록
연도 주식 분할 배수 누적 배수
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 주식 분할